Quantum Biopharma (QNTM) Prepaid Assets (2018 - 2025)
Quantum Biopharma's (QNTM) quarterly Prepaid Assets came in at $15290.0 in Q4 2025, down 77.85% year-on-year from $69036.0 in Q4 2024, and down 77.85% quarter-over-quarter from $69036.0 in Q4 2024.
Quantum Biopharma (QNTM) Prepaid Assets (2018 - 2025) Analysis & Trends
Quantum Biopharma has disclosed Prepaid Assets across 8 years of filings, most recently posting $15290.0 for Q4 2025.
- Prepaid Assets for Q4 2025 came in at $15290.0, down 77.85% year-over-year; the trailing twelve-month figure through Dec 2025 was $15290.0 (down 77.85% YoY), and the FY2025 annual result was $15290.0, down 77.85% from the prior year.
- Prepaid Assets came in at $15290.0 for Q4 2025 at Quantum Biopharma, down from $69036.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.4 million in Q4 2021 to a low of $15290.0 in Q4 2025.
- The 5-year median for Prepaid Assets is $155413.0 (2023), against an average of $415659.4.
- Across the five-year window, Prepaid Assets soared 139.98% in 2021 and slumped 77.85% in 2025, its largest moves.
- Quantum Biopharma's Prepaid Assets stood at $1.4 million in 2021, then tumbled by 65.45% to $472137.0 in 2022, then sank by 67.08% to $155413.0 in 2023, then plunged by 55.58% to $69036.0 in 2024, then plunged by 77.85% to $15290.0 in 2025.
- The last three Prepaid Assets figures came in at $15290.0 (Q4 2025), $69036.0 (Q4 2024), and $155413.0 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,290.00 |
| Dec 31, 2024 | 69,036.00 |
| Dec 31, 2023 | 155,413.00 |
| Dec 31, 2022 | 472,137.00 |
| Dec 31, 2021 | 1.37 Mn |
| Dec 31, 2020 | 569,401.00 |
| Jun 30, 2020 | -159,988.28 |
| Dec 31, 2019 | 326,012.90 |
| Jun 30, 2019 | 303,051.82 |
| Dec 31, 2018 | 336,458.19 |